Pluristem Therapeutics Depreciation & Amortization 2011-2026 | PSTI

Annual Depreciation & Amortization Pluristem Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
316 K	253 K	362 K	1.05 M	1.37 M	1.57 M	1.96 M	2.02 M	2.18 M	2.15 M	2.07 M	1.9 M	1.03 M	435 K	312 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.18 M	253 K	1.27 M

Quarterly Depreciation & Amortization Pluristem Therapeutics

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
129 K	130 K	-	-	68 K	65 K	-	-	-	67 K	-	-	-	100 K	197 K	-	-	337 K	664 K	-	-	347 K	695 K	347 K	-	468 K	853 K	468 K	-	503 K	-	-	-	515 K	1.02 M	515 K	-	558 K	1.11 M	558 K	-	497 K	1.03 M	497 K	-	498 K	1 M	498 K	-	461 K	937 K	461 K	-	130 K	276	130 K	-	97 K	199 K	97 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.11 M	276	439 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
INmune Bio INMB	84 K	$ 1.55	0.65 %	$ 38.4 M	USA
ACADIA Pharmaceuticals ACAD	920 K	$ 22.82	2.1 %	$ 3.78 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.51	0.29 %	$ 5.78 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.4	-0.09 %	$ 2.98 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 53.41	1.97 %	$ 4.8 B	Schweiz
Autolus Therapeutics plc AUTL	8.3 M	$ 1.68	2.44 %	$ 447 M	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands